logo
12:49 Apr 30

Syngene International Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
506.10
+73.95 (+17.11%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Syngene International Ltd. Financials

Syngene International Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
506.10
+73.95 (+17.11%)
12:49 Apr 30
Quality
image/svg+xml

45/100
Medium Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

44/100
Technically Neutral

Strength

8

Weakness

7

Opportunity

0

Threats

0

6.54 %

ROE %

4.48 %

ROA %

7.86

EPS

120.11

BVPS

8.47 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
2604.2 3192.9 3488.6 3642.4 3738.7
Operating Expenses +
1808.1 2258.5 2474.2 2600.6 2820.2
Raw Material
770.6 902.2 873.6 925.4 911.2
Increase Decrease in Cost
-21.6 -42 56.6 17.1 7.4
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
718.1 841.7 888.7 983.9 1104.9
Miscellaneous Expenses
341 556.6 655.3 674.2 796.7
Operating Profit
796.1 934.4 1014.4 1041.8 918.5
Other Income
52.8 70.9 90.6 71.8 70.7
Depreciation
309.7 366.5 425.9 432.6 452.9
Interest
24.1 45.2 47.2 53.1 48.8
Profit before tax and exceptio..
515.1 593.6 631.9 627.9 487.5
Exceptional Items
-30.7 0 -11.1 32 -76.6
PBT
484.4 593.6 620.8 659.9 410.9
Provision for Taxation
88.6 129.2 110.8 163.7 94.2
Net Profit
395.8 464.4 510 496.2 316.7
NET Profit after MI
395.8 464.4 510 496.2 316.7
EPS
9.82 11.51 12.69 12.34 7.87
Operating Profit Margin (%)
30.57 29.26 29.08 28.6 24.57
Net Profit Margin (%)
15.2 14.54 14.62 13.62 8.47

Syngene International Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: